- Immune Checkpoint Inhibitors and Their Cardiovascular Adverse Effects
Ravi Kumar Paluri et al, 2023, Oncology Reviews CrossRef - Influence of Antibiotic Use on the Effectiveness and Safety of Immune Checkpoint Inhibitors
Takuya Minamishima et al, 2022, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) CrossRef - Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
Evan R. Barry et al, 2021, Cells CrossRef - Survival Benefit of Statin with Anti-Angiogenesis Efficacy in Lung Cancer-Associated Pleural Fluid through FXR Modulation
Chen-Liang Tsai et al, 2022, Cancers CrossRef - Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic
Adrián Bouzas et al, 2022, Frontiers in Oncology CrossRef - Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma
Alejandro Escobedo-Calvario et al, 2022, Exploration of Digestive Diseases CrossRef - Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment
Jingtao Tong et al, 2021, Cancer Management and Research CrossRef - Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy
Huixian Zhang et al, 2021, OncoTargets and Therapy CrossRef - Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling
Woo-Jin Lim et al, 2021, Cells CrossRef - Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization
Aryeh Silver et al, 2022, Frontiers in Oncology CrossRef - A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids
Yang Yu et al, 2021, Frontiers in Oncology CrossRef - High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients
Luca Cantini et al, 2021, European Journal of Cancer CrossRef - Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study
Toshiki Ogiwara et al, 2021, Frontiers in Oncology CrossRef - Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations
Xiangbing Meng et al, 2021, Frontiers in Medicine CrossRef - Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis
Lei Zhang et al, 2022, International Journal of Clinical Practice CrossRef - Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
Tove Selvin et al, 2023, BMC Cancer CrossRef - Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
Tove Selvin et al, 2024, BMC Pharmacology and Toxicology CrossRef - Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells
Thuzar Hla Shwe et al, 2021, International Journal of Molecular Sciences CrossRef